Asarina Pharma AB

Revision as of 13:29, 15 August 2022 by 103.126.60.198 (talk)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

SummaryEdit

Asarina Pharma AB (publ), a biotech company, researches and develops pharmaceutical products. Its flagship product is Sepranolone, which is used for the treatment of menstrual migraine and Tourette syndrome. The company was formerly known as Umecrine Mood AB and changed its name to Asarina Pharma AB (publ) in 2016. Asarina Pharma AB (publ) was incorporated in 2005 and is based in Solna, Sweden.